Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
of analytical and numerical techniques to provide better understanding of and control over the fundamental properties of light-matter interactions and in this way realizing new nanophotonic devices
-
related child data providing the opportunity for mutual sparring and support. As part of the PhD you also have the opportunity to spend some months at the Department of Prevention, Health Promotion and
-
the closed-loop system on new molecular scaffolds. Contributing to cross-disciplinary education by providing case studies on computational and empirical method integration. Qualifications You must have a two
-
committees appointed by the dean here . Applicants are very much encouraged to supply documentation as to how they rank compared to their class (both Bachelor’s and Master’s degrees). This may for example be
-
PhD scholarship in Biomaterials-based Approach for the Creation of Artificial Red Blood Cells - D...
are essential, but they come with challenges: Short shelf life and global supply limitations The need for blood-type matching in emergencies Risk of transmitting infections, such as HIV in the past This project
-
about our work: www.healthtech.dtu.dk/3bs . About the project: Artificial red blood cells Blood transfusions are essential, but they come with challenges: Short shelf life and global supply limitations
-
responsibility. The JRC provides independent, evidence-based knowledge and science, supporting EU policies to positively impact society. JRC’s Collaborative Doctoral Partnerships (CDP) is an initiative of the JRC
-
PhD programme is available at the department’s website . On the website, you will also find the department’s qualifications criteria . The programme is provided by the PhD School at the Faculty
-
in Newcastle, UK. Visits with these collaborators are expected. Our group and research- and what do we offer? The successful applicant will join the BioComplexity section. The section provides a highly
-
tools from chemistry and biology, and apply these in studies of therapeutic peptides and proteins. Our aims are to develop modulators for protein-protein interactions (PPIs) and to provide molecular-level